Upon AML development, iMLL-AF9;Nes-CreERT2;iDTA or FLT3-ITD;NPMc;iDTA mice and their control iDTA littermates were treated with chemotherapy alone, or in combination with tamoxifen, to deplete nestin+ cells (Figure 4A). This evidence concerns the gene NES and acute myeloid leukemia.